Publications by authors named "L Dori"

Article Synopsis
  • Increased rates of indeterminate QuantiFERON-TB Gold Plus Assay (QFT-Plus) were observed in hospitalized COVID-19 patients, with a 22.1% indeterminacy rate overall, higher among non-survivors and severe cases.
  • The study involved 420 patients, primarily older adults (median age 65), analyzing their immune response, specifically interferon-gamma (IFN-γ) production and T-lymphocyte counts.
  • Findings indicated that lower counts of CD3+ T-cells and a skewed CD4/CD8 ratio were significant predictors of indeterminate QFT-Plus results, linking immune system depletion in severe COVID-19 with increased indeterminacy.
View Article and Find Full Text PDF

A full term boy was admitted with respiratory distress in the fourth week of his life due to spontaneous chylothorax in his right hemithorax. Spontaneous chylothorax occurred previously in a first cousin of the neonate establishing that way the final diagnosis of familial idiopathic congenital pneumothorax. Failure of the conservative treatment consisting of chest tube drainage, discontinuation of oral diet and administration of total parenteral nutrition in combination with octreotide for one month was followed by the successful ligation of the thoracic duct through a right thoracotomy.

View Article and Find Full Text PDF

Objective: The impact of HIV-1 tropism on the emergence of non-AIDS events was evaluated in a cohort of 116 antiretroviral therapy (ART) responder patients.

Methods: The patients were followed for the emergence of hypertension, renal impairment, metabolic and bone disorders (defined as non-AIDS events) each 8 weeks at standard visits. A V3 plasma sequence genotype analysis was performed at the time of ART initiation and the geno2pheno algorithm with the results that defines the false-positive rate (FPR) was used to infer HIV tropism.

View Article and Find Full Text PDF

Through this study we evaluated whether the HIV-1 tropism determined by genotypic analysis correlates with HIV-1 markers, such as CD4 cell count and plasma HIV-RNA. The analysis was performed on 1221 HIV-1 B-subtype infected patients with an available V3 sequence (all maraviroc naive). Of them, 532 were antiretroviral therapy (ART) naive and 689 ART experienced.

View Article and Find Full Text PDF